Literature DB >> 29052061

Comparison of two new techniques for the management of malignant central airway obstruction: argon plasma coagulation with mechanical tumor resection versus cryorecanalization.

Derya Kızılgöz1, Zafer Aktaş2, Aydın Yılmaz2, Ayperi Öztürk2, Fatih Seğmen3.   

Abstract

BACKGROUND: The development of central airway obstruction during malignant diseases is an important cause of morbidity and mortality. Endobronchial therapies can decrease the patient's symptoms and improve quality of life. Here, we compare airway recanalization methods: argon plasma coagulation with mechanical tumor resection (APC + MTR) and cryorecanalization (CR efficiency, complications, restenosis rate, and time to restenosis) in patients with malignant exophytic endobronchial airway obstruction.
METHODS: A total of 89 patients were included who were admitted to our hospital between 2005 and 2012. The data were analyzed retrospectively. Initially, a CR procedure was performed in 52 patients using rigid bronchoscopy under general anesthesia; the APC + MTR procedure was performed in 37 patients with malignant airway obstruction.
RESULTS: The airway patency rate with APC + MTR was 97.3% (n = 36) and CR was 80.8% (n = 42). The APC + MTR procedure was more effective than CR for recanalization of malignant endobronchial exophytic airway obstruction. Additionally, the achievement rate of airway patency with APC + MTR was significantly higher in tumors with distal bronchial involvement. There was no statistically significant difference between groups in terms of complications, restenosis rate, and time to restenosis.
CONCLUSIONS: The APC + MTR procedure is preferred over CR to introduce and maintain airway patency in patients with malignancy-related endobronchial exophytic airway obstruction.

Entities:  

Keywords:  Argon plasma coagulation; Central airway obstruction; Cryorecanalization; Interventional bronchoscopy; Lung cancer; Mechanical tumor resection

Mesh:

Year:  2017        PMID: 29052061     DOI: 10.1007/s00464-017-5877-2

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  14 in total

1.  ERS/ATS statement on interventional pulmonology. European Respiratory Society/American Thoracic Society.

Authors:  C T Bolliger; P N Mathur; J F Beamis; H D Becker; S Cavaliere; H Colt; J P Diaz-Jimenez; J F Dumon; E Edell; K L Kovitz; H N Macha; A C Mehta; M Marel; M Noppen; J Strausz; T G Sutedja
Journal:  Eur Respir J       Date:  2002-02       Impact factor: 16.671

2.  Cryorecanalization: a new approach for the immediate management of acute airway obstruction.

Authors:  Martin Hetzel; Juergen Hetzel; Christian Schumann; Nikolaus Marx; Alexander Babiak
Journal:  J Thorac Cardiovasc Surg       Date:  2004-05       Impact factor: 5.209

3.  Cryorecanalization: keys to success.

Authors:  Aydin Yilmaz; Zafer Aktaş; Ibrahim Onur Alici; Atalay Cağlar; Hilal Sazak; Fatma Ulus
Journal:  Surg Endosc       Date:  2012-05-19       Impact factor: 4.584

4.  [Argon plasma coagulation in bronchology: a new method--alternative or complementary?].

Authors:  G Reichle; L Freitag; H J Kullmann; R Prenzel; H N Macha; G Farin
Journal:  Pneumologie       Date:  2000-11

Review 5.  Clinical aspects and treatment of primary tracheal malignancies.

Authors:  Jimmie Honings; Henning A Gaissert; Henricus F M van der Heijden; Ad F T M Verhagen; Johannes H A M Kaanders; Henri A M Marres
Journal:  Acta Otolaryngol       Date:  2010-07       Impact factor: 1.494

6.  Argon plasma coagulation and electrosurgery for benign endobronchial tumors.

Authors:  Stacey M Miller; Christina R Bellinger; Arjun Chatterjee
Journal:  J Bronchology Interv Pulmonol       Date:  2013-01

7.  Endobronchial tumor debulking with a flexible cryoprobe for immediate treatment of malignant stenosis.

Authors:  Christian Schumann; Martin Hetzel; Alexander J Babiak; Jürgen Hetzel; Tobias Merk; Thomas Wibmer; Philipp M Lepper; Stefan Krüger
Journal:  J Thorac Cardiovasc Surg       Date:  2009-08-27       Impact factor: 5.209

8.  Silicone stents in the management of inoperable tracheobronchial stenoses. Indications and limitations.

Authors:  C T Bolliger; R Probst; K Tschopp; M Solèr; A P Perruchoud
Journal:  Chest       Date:  1993-12       Impact factor: 9.410

9.  Incidence of local recurrence and second primary tumors in resected stage I lung cancer.

Authors:  N Martini; M S Bains; M E Burt; M F Zakowski; P McCormack; V W Rusch; R J Ginsberg
Journal:  J Thorac Cardiovasc Surg       Date:  1995-01       Impact factor: 5.209

10.  [Efficacy and safety of argon plasma coagulation in the treatment of obstructive tracheobronchial stenosis].

Authors:  Fa-guang Jin; De-guang Mu; Dong-ling Chu; En-qing Fu; Yong-hong Xie; Tong-gang Liu; Xing Gu
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2008-06
View more
  4 in total

Review 1.  Minimally invasive palliative interventions in advanced lung cancer.

Authors:  Christopher Mallow; Margaret Hayes; Roy Semaan; Thomas Smith; Russell Hales; Roy Brower; Lonny Yarmus
Journal:  Expert Rev Respir Med       Date:  2018-06-19       Impact factor: 3.772

2.  Prospective Multicentered Safety and Feasibility Pilot for Endobronchial Intratumoral Chemotherapy.

Authors:  Lonny Yarmus; Christopher Mallow; Jason Akulian; Cheng Ting Lin; David Ettinger; Russell Hales; Kinh Ranh Voong; Hans Lee; David Feller-Kopman; Roy Semaan; Kirk Seward; Momen M Wahidi
Journal:  Chest       Date:  2019-02-15       Impact factor: 9.410

3.  Bronchial arterial embolization may reduce the risk of severe bleeding in central airway obstruction due to renal cell carcinomas during bronchoscopic procedures.

Authors:  Meimei Tao; Nan Zhang; Hongwu Wang; Hongming Ma; Hong Gao; Zhina Wang
Journal:  Ther Adv Respir Dis       Date:  2020 Jan-Dec       Impact factor: 4.031

4.  Clinical effects of cisplatin plus recombinant human endostatin (rh-endostatin) intratumoral injection on malignant central airway obstruction: a retrospective analysis of 319 cases.

Authors:  Yunzhi Zhou; Yongping Gao; Nan Zhang; Xiaoli Li; Hui Wang; Shufang Wang; Jiankun Liu; Hong Gao; Hongwu Wang
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 2.895

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.